HF
CLMT icon

HRT Financial’s Calumet Specialty Products CLMT Stock Holding History

HRT Financial’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-98,600
Closed -$1.96M – 3904
2025
Q4 		$1.96M Buy
+98,600
New +$1.9M 0.01% 1319

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

HRT Financial's CLMT Position: Q1 2026 in Review

HRT Financial opened a new position in Calumet Specialty Products (CLMT) in Q1 2026: 118,290 shares worth $4.25M. The stake represents 0.01% of the portfolio and ranks #1105 among its holdings. This is a return to the name: HRT Financial previously reported a position in CLMT as recently as Q1 2025.

HRT Financial first reported a position in CLMT in Q4 2021 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • HRT Financial held 118,290 shares of Calumet Specialty Products worth $4.25M as of Q1 2026.
  • Calumet Specialty Products was a new HRT Financial position in Q1 2026.
  • Calumet Specialty Products made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1105 holding.
  • HRT Financial first reported a position in Calumet Specialty Products in Q4 2021 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.